{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:34Z","timestamp":1791356194763,"version":"4.3.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/med.0000000000000093","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T13:04:27Z","timestamp":1407416667000},"page":"345-351","source":"Crossref","is-referenced-by-count":129,"title":["Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction"],"prefix":"10.1097","volume":"21","author":[{"given":"Harold","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20211004","first-page":"2461","article-title":"Adiposopathy is sick fat a cardiovascular disease J Am Coll C","volume":"57","author":"Bays","year":"2011","journal-title":"ardiol"},{"key":"R2-6-20211004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","article-title":"Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R3-6-20211004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semnephrol.2012.12.006","article-title":"Obesity and kidney disease: potential mechanisms.","volume":"33","author":"Wickman","year":"2013","journal-title":"Semin Nephrol"},{"key":"R4-6-20211004","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MCO.0b013e328358be7b","article-title":"The role of cardiac fat in insulin resistance.","volume":"15","author":"Gastaldelli","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R5-6-20211004","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1042\/BST0331049","article-title":"Adipose tissue changes in obesity.","volume":"33","author":"Coppack","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"R6-6-20211004","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/oby.2010.230","article-title":"Systemic effects of white adipose tissue dysregulation and obesity-related inflammation.","volume":"19","author":"Guri","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"R7-6-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2012.10.001","article-title":"Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.","volume":"34","author":"Lee","year":"2013","journal-title":"Mol Asp Med"},{"key":"R8-6-20211004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/met.2009.0089","article-title":"Anthropometric measurements and diabetes mellitus: clues to the pathogenic and protective potential of adipose tissue.","volume":"8","author":"Bays","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"key":"R9-6-20211004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"R12-6-20211004","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/oby.20705","article-title":"Induction of adipocyte hyperplasia in subcutaneous fat depot alleviated type 2 diabetes symptoms in obese mice.","volume":"22","author":"Lu","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"R13-6-20211004","first-page":"389","article-title":"Adiposopathy: why do adiposity and obesity cause metabolic disease Future L","volume":"1","author":"Bays","year":"2006","journal-title":"ipidol"},{"key":"R14-6-20211004","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2008.10.015","article-title":"Sick fat, metabolic disease, and atherosclerosis.","volume":"122","author":"Bays","year":"2009","journal-title":"Am J Med"},{"key":"R15-6-20211004","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","article-title":"Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.","volume":"7","author":"Bays","year":"2013","journal-title":"J Clin Lipidol"},{"key":"R16-6-20211004","doi-asserted-by":"crossref","first-page":"4B","DOI":"10.1016\/j.amjcard.2012.08.029","article-title":"Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating sick fat through improving fat function with antidiabetes therapies.","volume":"110","author":"Bays","year":"2012","journal-title":"Am J Cardiol"},{"key":"R17-6-20211004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mam.2012.10.004","article-title":"Metabolically healthy obesity: origins and implications.","volume":"34","author":"Denis","year":"2013","journal-title":"Mol Asp Med"},{"key":"R18-6-20211004","doi-asserted-by":"crossref","first-page":"489187","DOI":"10.1155\/2013\/489187","article-title":"Role of subcutaneous adipose tissue in the pathogenesis of insulin resistance.","volume":"2013","author":"Patel","year":"2013","journal-title":"J Obes"},{"key":"R19-6-20211004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2458-14-14","article-title":"Beyond BMI: The Metabolically healthy obese phenotype its association with clinicalsubclinical cardiovascular disease and all-cause mortality - a systematic review.","volume":"14","author":"Roberson","year":"2014","journal-title":"BMC Public Health"},{"key":"R20-6-20211004","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions: a systematic review and meta-analysis.","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Int Med"},{"key":"R21-6-20211004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcn\/87.1.56","article-title":"Subcutaneous adipocyte size and body fat distribution.","volume":"87","author":"Tchoukalova","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R22-6-20211004","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11883-014-0409-1","article-title":"Adiposopathy, Sick Fat, Ockhams Razor, and resolution of the Obesity Paradox.","volume":"16","author":"Bays","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"R25-6-20211004","doi-asserted-by":"crossref","first-page":"E999","DOI":"10.1152\/ajpendo.00377.2009","article-title":"Inflammation and impaired adipogenesis in hypertrophic obesity in man.","volume":"297","author":"Gustafson","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 4","key":"R26-6-20211004","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijo.0802853","article-title":"Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.","volume":"28","author":"Heilbronn","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R27-6-20211004","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbalip.2011.09.010","article-title":"Fatty acid transport proteins, implications in physiology and disease.","volume":"1821","author":"Kazantzis","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R28-6-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20110151","article-title":"Perivascular adipose tissue: more than just structural support.","volume":"122","author":"Szasz","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"R29-6-20211004","doi-asserted-by":"crossref","first-page":"E937","DOI":"10.1152\/ajpendo.00061.2012","article-title":"Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease.","volume":"303","author":"Cherian","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R30-6-20211004","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2003-030723","article-title":"Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach.","volume":"89","author":"Bays","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-6-20211004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11684-013-0288-9","article-title":"The mechanisms linking adiposopathy to type 2 diabetes.","volume":"7","author":"Yang","year":"2013","journal-title":"Front Med"},{"key":"R32-6-20211004","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.2337\/db10-1263","article-title":"Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-kappaB stress pathway.","volume":"60","author":"Le","year":"2011","journal-title":"Diabetes"},{"key":"R33-6-20211004","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1054\/mehy.2001.1317","article-title":"Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity.","volume":"57","author":"McCarty","year":"2001","journal-title":"Med Hypotheses"},{"key":"R34-6-20211004","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2337\/diabetes.55.04.06.db05-1414","article-title":"Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.","volume":"55","author":"Laviola","year":"2006","journal-title":"Diabetes"},{"key":"R35-6-20211004","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1172\/JCI200422028","article-title":"The case of visceral fat: argument for the defense.","volume":"113","author":"Klein","year":"2004","journal-title":"J Clin Invest"},{"key":"R36-6-20211004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/nu5020498","article-title":"Fat depots, free fatty acids, and dyslipidemia.","volume":"5","author":"Ebbert","year":"2013","journal-title":"Nutrients"},{"key":"R37-6-20211004","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Nonalcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"R38-6-20211004","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/j.gastro.2010.04.056","article-title":"Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.","volume":"139","author":"Fabbrini","year":"2010","journal-title":"Gastroenterology"},{"key":"R39-6-20211004","first-page":"1285","article-title":"Adiposopathy and bariatric surgery: is sick fat a surgical disease Int J Clin P","volume":"63","author":"Bays","year":"2009","journal-title":"ract"},{"key":"R40-6-20211004","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beem.2013.02.005","article-title":"Adipose tissue dysfunction contributes to obesity related metabolic diseases.","volume":"27","author":"Bluher","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R41-6-20211004","doi-asserted-by":"crossref","first-page":"e9997","DOI":"10.1371\/journal.pone.0009997","article-title":"The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity.","volume":"5","author":"OConnell","year":"2010","journal-title":"PLoS One"},{"key":"R42-6-20211004","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1373\/clinchem.2007.100156","article-title":"The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences.","volume":"54","author":"De Ferranti","year":"2008","journal-title":"Clin Chem"},{"key":"R44-6-20211004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2010.02.004","article-title":"Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation.","volume":"86","author":"Caso","year":"2010","journal-title":"Antivir Res"},{"key":"R45-6-20211004","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/MOL.0b013e32834c7cfc","article-title":"Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic.","volume":"22","author":"Schattenberg","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"R46-6-20211004","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R47-6-20211004","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/oby.2010.90","article-title":"Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction.","volume":"18","author":"Magkos","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"R48-6-20211004","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/oby.2009.454","article-title":"Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans.","volume":"18","author":"Perreault","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"R49-6-20211004","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/oby.20114","article-title":"Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype.","volume":"21","author":"Petaja","year":"2013","journal-title":"Obesity (Silver Spring)"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201410000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T13:07:17Z","timestamp":1633525637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201410000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0000000000000093","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}